Please login to the form below

secukinumab

This page shows the latest secukinumab news and features for those working in and with pharma, biotech and healthcare.

Novartis buys cancer specialist Endocyte for $2.1bn

psoriasis drug Cosentyx (secukinumab) and Entresto (sacubitril/valsartan) for heart failure – up 37% to $750m and 113% to $271m, respectively – as well as Sandoz’biosimilar drugs.

Latest news

Amgen’s R&D chief Sean Harper retires to seek biotech post

from biosimilars and newer drugs such as Novartis’fast-growing IL-17 inhibitor Cosentyx (secukinumab).
Novartis follows Pfizer and freezes US prices this year

Novartis’decision to keep pricing steady has been helped by a rosy set of second-quarter results, with recent launches Cosentyx (secukinumab) for psoriasis and heart failure therapy Entresto (sacubitril and
GSK sells eczema and psoriasis drug to Dermavant for £250m

In the case of psoriasis, that includes not only new therapies such as Novartis’IL-17 inhibitor Cosentyx (secukinumab) and Johnson &Johnson’s IL-23/IL-12 inhibitor Tremfya (guselkumab), but
UK, Germany back routine use of J&J’s Tremfya

psoriasis therapies such as Novartis’fast-growing IL-17 inhibitor Cosentyx (secukinumab), which EvaluatePharma expects to become a $4.6bn product by 2022.
Sun Pharma passes milestone with novel psoriasis drug approval

IL-23-selective follow-up Tremfya (guselkumab) as well as three IL-17 inhibitors - Novartis’ Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) and Valeant Pharma’s Siliq (brodalumab).

More from news
Approximately 16 fully matching, plus 61 partially matching documents found.

Latest appointments

AIMM Therapeutics appoints former Novartis VP Jan de Vries as CEO

multiple sclerosis and secukinumab for several inflammatory conditions.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Executive, London, Medical Communications: Excellent package

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Account Director: Excellent benefits

Account Manager / Senior Account Manager: 35, 000-40, 000

Consultant Health Economics - London / Oxford: Negotiable

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Project / Account Manager (Medical Education): Salary TBC

Senior Medical Writer: Competitive Salary

Production Manager – Healthcare Communications: DOE

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Client Services Director – Medical Education Agency – North West...: Salary TBC

Director, Market Access / HEOR - North-West: Negotiable

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Manager / Account Director: Competative

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Scientific Director / Editorial Team Leader: Great salary and benefits

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Associate Director: £75, 000-90, 000

Events Manager – Med Comms – Surrey: Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...